Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 486,425 | 1,575,794 | 1,213,656 | 815,337 | 407,407 |
| Depreciation Amortization | 29,635 | 101,360 | 41,814 | 26,282 | 11,671 |
| Income taxes - deferred | 4,263 | 113,384 | 93,589 | 39,804 | 7,848 |
| Accounts receivable | -141,022 | -138,034 | -162,026 | -115,322 | -74,836 |
| Accounts payable and accrued liabilities | 104,674 | -77,549 | -104,043 | -101,783 | -71,150 |
| Other Working Capital | 58,117 | -332,381 | -233,805 | -2,353 | -841 |
| Other Operating Activity | 63,419 | 426,508 | 404,227 | 340,249 | 210,394 |
| Operating Cash Flow | $605,511 | $1,669,082 | $1,253,412 | $1,002,214 | $490,493 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -106,467 | -1,172,376 | -1,061,722 | -724,923 | -565,390 |
| PPE Investments | -16,749 | -78,648 | -64,326 | -46,830 | -25,041 |
| Net Acquisitions | N/A | -46,443 | -46,443 | N/A | N/A |
| Purchase Of Investment | N/A | -5,000 | N/A | N/A | N/A |
| Investing Cash Flow | $-123,216 | $-1,302,467 | $-1,172,491 | $-771,753 | $-590,431 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -97 | -99,459 | -99,377 | -99,248 | -99,137 |
| Common Stock Issued | 65,480 | 243,427 | 186,350 | 148,487 | 83,586 |
| Common Stock Repurchased | -815,936 | -487,543 | -454,888 | -454,888 | N/A |
| Other Financing Activity | 60,831 | 172,592 | 85,279 | 68,861 | 33,770 |
| Financing Cash Flow | $-689,722 | $-170,983 | $-282,636 | $-336,788 | $18,219 |
| Exchange Rate Effect | -37,775 | -43,553 | -30,164 | -8,032 | -5,146 |
| Beginning Cash Position | 968,086 | 816,007 | 816,007 | 816,007 | 816,007 |
| End Cash Position | 722,884 | 968,086 | 584,128 | 701,648 | 729,142 |
| Net Cash Flow | $-245,202 | $152,079 | $-231,879 | $-114,359 | $-86,865 |
| Free Cash Flow | |||||
| Operating Cash Flow | 605,511 | 1,669,082 | 1,253,412 | 1,002,214 | 490,493 |
| Capital Expenditure | -16,749 | -78,648 | -64,326 | -46,830 | -25,041 |
| Free Cash Flow | 588,762 | 1,590,434 | 1,189,086 | 955,384 | 465,452 |